Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors.

× No keyword cloud information.

325 in total

1. Allosteric control of gating and kinetics at P2X(4) receptor channels.

Authors: B S Khakh; W R Proctor; T V Dunwiddie; C Labarca; H A Lester
Journal: J Neurosci Date: 1999-09-01 Impact factor: 6.167

2. Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction.

Authors: P V Piazza; V Deroche-Gamonent; F Rouge-Pont; M Le Moal
Journal: J Neurosci Date: 2000-06-01 Impact factor: 6.167

3. Allosteric modulators affect the efficacy of partial agonists for recombinant GABA(A) receptors.

Authors: G Maksay; S A Thompson; K A Wafford
Journal: Br J Pharmacol Date: 2000-04 Impact factor: 8.739

4. Agonist binding to G-protein coupled receptors.

Authors: P G Strange
Journal: Br J Pharmacol Date: 2000-02 Impact factor: 8.739

5. Substrate turnover by transporters curtails synaptic glutamate transients.

Authors: S Mennerick; W Shen; W Xu; A Benz; K Tanaka; K Shimamoto; K E Isenberg; J E Krause; C F Zorumski
Journal: J Neurosci Date: 1999-11-01 Impact factor: 6.167

6. Single-channel properties of neuronal GABAA receptors from mice lacking the 2 subunit.

Authors: M Lorez; D Benke; B Luscher; H Mohler; J A Benson
Journal: J Physiol Date: 2000-08-15 Impact factor: 5.182

7. Disparate ligand-mediated Ca(2+) responses by wild-type, mutant Ser(200)Ala and Ser(204)Ala alpha(2A)-adrenoceptor: G(alpha15) fusion proteins: evidence for multiple ligand-activation binding sites.

Authors: P J Pauwels; F C Colpaert
Journal: Br J Pharmacol Date: 2000-08 Impact factor: 8.739

Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors.